Department of Basic Medical Sciences, Neuroscience and Sensory Organs, University of Bari, School of Medicine, Bari, Italy.
MEBIC Consortium, San Raffaele Open University of Rome and IRCCS San Raffaele Pisana of Rome, Rome, Italy.
Curr Pharm Des. 2018;24(10):1148-1156. doi: 10.2174/1381612824666180327155230.
Antimicrobial Peptides (AMPs) are produced by a variety of human immune and non immune cells in health and disease. In virtue of their antimicrobial activity, AMPs have been exploited in human disease and here this aspect will extensively be described. AMPs in comparison to antibiotics possess a larger spectrum of antimicrobial activity without inducing microbial resistance. Therefore, their use in the course of antibiotic-resistant infections is justified. AMP activity in early life, in the airways, in the oral and gastro-enteric system, in the skin and in the female reproductive tract, respectively, will be elucidated. In addition, the use of AMPs in sepsis will be discussed due to the frequency of this pathological condition characterized by multiple organ dysfunctions. Finally, the evidence that AMPs represent valid substitutes of antibiotics will be provided and a series of novel substances able to reinforce the innate immune response in different clinical settings will be discussed.
抗菌肽(AMPs)在健康和疾病状态下由多种人体免疫和非免疫细胞产生。由于其抗菌活性,AMPs 已被广泛应用于人类疾病,本文将对此进行详细描述。与抗生素相比,AMPs 具有更大的抗菌活性谱,而不会诱导微生物耐药性。因此,在抗生素耐药性感染的治疗中使用 AMPs 是合理的。本文将分别阐述 AMPs 在生命早期、气道、口腔和胃肠道系统、皮肤和女性生殖系统中的作用。此外,还将讨论 AMPs 在败血症中的应用,因为败血症是一种以多器官功能障碍为特征的病理状态,其发病率较高。最后,本文将提供 AMPs 可以作为抗生素替代品的证据,并讨论一系列可在不同临床环境下增强固有免疫反应的新型物质。